The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘
Open accessAbstract
Objective To investigate differences in manifestations and outcomes of coronavirus disease 2019 (COVID-19) infection between those with and without rheumatic disease. Methods We conducted a comparative cohort study of patients with rheumatic disease and COVID-19 (confirmed by severe acute respiratory syndrome coronavirus 2 PCR), compared in a 1:2 ratio with matched comparators on age, sex and date of COVID-19 diagnosis, between 1 March and 8 April 2020, at Partners HealthCare System in the greater Boston, Massachusetts area. We examined differences in demographics, clinical features and outcomes of COVID-19 infection. The main outcomes were hospitalisation, intensive care admission, mechanical ventilation and mortality. Results We identified 52 rheumatic disease patients with COVID-19 (mean age, 63 years; 69% female) and matched these to 104 non-rheumatic disease comparators. The majority (39, 75%) of patients with rheumatic disease were on immunosuppressive medications. Patients with and without rheumatic disease had similar symptoms and laboratory findings. A similar proportion of patients with and without rheumatic disease were hospitalised (23 (44%) vs 42 (40%)), p=0.50) but those with rheumatic disease required intensive care admission and mechanical ventilation more often (11 (48%) vs 7 (18%), multivariable OR 3.11 (95% CI 1.07 to 9.05)). Mortality was similar between the two groups (3 (6%) vs 4 (4%), p=0.69). Conclusions Patients with rheumatic disease and COVID-19 infection were more likely to require mechanical ventilation but had similar clinical features and hospitalisation rates as those without rheumatic disease. These findings have important implications for patients with rheumatic disease but require further validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COVID-19 and African Americans
Yancy, C. W. (2020) · JAMA · doi:10.1001/jama.2020.6548 · Cited by 1,934
COVID-19 exacerbating inequalities in the US
Dorn, A. V., Cooney, R. E., & Sabin, M. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30893-x · Cited by 1,315
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266
Tocilizumab treatment in COVID‐19: A single center experience
Luo, P., Liu, Y., Qiu, L., Liu, X., Liu, D., & Li, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25801 · Cited by 1,237
What we know so far: COVID-19 current clinical knowledge and research
Lake, M. A. (2020) · Clinical Medicine · doi:10.7861/clinmed.2019-coron · Cited by 800
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
D’Antiga, L. (2020) · Liver Transplantation · doi:10.1002/lt.25756 · Cited by 664
Hui, D. S., Azhar, E. I., Kim, Y.-J., Memish, Z. A., Oh, M.-D., & Zumla, A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30127-0 · Cited by 448
Monti, S., Balduzzi, S., Delvino, P., Bellis, E., Quadrelli, V. S., & Montecucco, C. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217424 · Cited by 446
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
Haberman, R., Axelrad, J., Chen, A., Castillo, R., Yan, D., Izmirly, P., Neimann, A., Adhikari, S., Hudesman, D., & Scher, J. U. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009567 · Cited by 405
Calculating the benefits of a Research Patient Data Repository.
Nalichowski, R., Keogh, D., Chueh, H. C., & Murphy, S. N. (2006) · PubMed Central · Cited by 285
Cited by
Booth, A., Reed, A. B., Ponzo, S., Yassaee, A., Aral, M., Plans, D., Labrique, A., & Mohan, D. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247461 · Cited by 551
COVID-19 in Immunocompromised Hosts: What We Know So Far
Fung, M., & Babik, J. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa863 · Cited by 526
Avouac, J., Drumez, E., Hachulla, E., Seror, R., Georgin-Lavialle, S., El Mahou, S., Pertuiset, E., Pham, T., Marotte, H., Servettaz, A., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00059-x · Cited by 273
Pablos, J. L., Galindo, M., Carmona, L., Lledó, A., Retuerto, M., Blanco, R., Gonzalez-Gay, M. A., Martinez-Lopez, D., Castrejón, I., Alvaro-Gracia, J. M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218296 · Cited by 238
Conway, R., Grimshaw, A. A., Konig, M. F., Putman, M., Duarte‐García, A., Tseng, L. Y., Cabrera, D. M., Chock, Y. P. E., Degirmenci, H. B., Duff, E., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42030 · Cited by 178
Self-citation
Metadata
- Authors
- D'Silva, K. M., Serling-Boyd, N., Wallwork, R., Hsu, T., Fu, X., Gravallese, E. M., Choi, H. K., Sparks, J. A., & Wallace, Z. S.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 79
- Issue
- 9
- Pages
- 1156-1162
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W3030308448
- Cited by
- 267
- References
- 19
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘. https://app.cochat.ai/papers/10.1136/annrheumdis-2020-217888
- The paper
- D'Silva, K. M., Serling-Boyd, N., Wallwork, R., Hsu, T., Fu, X., Gravallese, E. M., Choi, H. K., Sparks, J. A., & Wallace, Z. S. (2020). Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217888
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.